Risk factor contributions to socioeconomic inequality in cardiovascular risk in the Philippines: a cross-sectional study of nationally representative survey data

被引：0
作者：
Callum Brindley
Tom Van Ourti
Joseph Capuno
Aleli Kraft
Jenny Kudymowa
Owen O’Donnell
机构：
[1] Erasmus University,Erasmus School of Health Policy and Management
[2] Erasmus University Rotterdam,Erasmus Centre for Health Economics
[3] Erasmus University Rotterdam,Erasmus School of Economics
[4] Tinbergen Institute,School of Economics
[5] University of the Philippines Diliman,Faculty of Economics and Business
[6] Rethink Priorities,undefined
[7] University of Lausanne,undefined
来源：
BMC Public Health | / 23卷
关键词：
Cardiovascular disease; Risk factors; Blood pressure; Blood glucose; Cholesterol; Smoking; Socioeconomic; Inequality; Decomposition; Philippines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
• Evidence on risk factor contributions to socioeconomic inequalities in cardiovascular disease (CVD) risk is needed to target prevention programmes and meet the SDG target of a one third reduction in premature non-communicable disease mortality by 2030.• In the Philippines, wealthier individuals have higher predicted CVD risks and greater exposure to all risk factors, except smoking.• Total Cholesterol (TC) and High Blood Glucose (HBG) contribute most to the higher CVD risks of wealthier Filipinos.• Wealth inequalities in TC and HBG, and (for males) in systolic blood pressure, are mostly explained by differences in body mass index and fat share of energy intake, and not by differences in physical exercise.• To maximise impact, CVD prevention in the Philippines should target diet programmes on wealthier groups and smoking programmes on poorer groups.
引用
收藏
相关论文
共 161 条
  • [1] Lim SS(2007)Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs The Lancet 370 2054-62
  • [2] Gaziano TA(2005)Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk The Lancet 365 434-41
  • [3] Gakidou E(2018)Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data PLoS Med 15 e1002538-71
  • [4] Jackson R(2019)Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study The Lancet 394 663-7
  • [5] Lawes C(2019)Strategies to identify patients for antihypertensive treatment The Lancet 394 615-57
  • [6] Bennett D(2020)2020 International Society of Hypertension Global Hypertension Practice Guidelines Hypertension 75 1334-33
  • [7] Milne R(2022)Explaining the Variance in Cardiovascular Disease Risk factors: a comparison of demographic, socioeconomic, and genetic predictors Epidemiology 33 25-14
  • [8] Rodgers A(2012)Socio-economic distribution of cardiovascular risk factors and knowledge in rural India Int J Epidemiol 41 1302-76
  • [9] Karmali KN(2016)Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data BMJ Open 6 e009195-26
  • [10] Lloyd-Jones DM(2018)Geographic and sociodemographic variation of cardiovascular disease risk in India: a cross-sectional study of 797,540 adults PLOS Med 15 e1002581-77
12345678910